Title: Weight-Loss War Explodes — Novo Nordisk Sues Hims Over ‘Illegal’ Wegovy Copycats, Millions of Americans Caught in the Middle
Key Points Shares of Novo Nordisk (NVO) jumped more than 5% Monday, while Hims & Hers (HIMS) plunged over 21% in early trading, as a major legal battle shook the booming U.S. weight-loss drug market. Novo Nordisk announced it is suing telehealth platform Hims & Hers, accusing the company of widely promoting cheaper, unapproved versions … Read more